These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26230338)

  • 1. Preferential Interactions and the Effect of Protein PEGylation.
    Holm LS; Thulstrup PW; Kasimova MR; van de Weert M
    PLoS One; 2015; 10(7):e0133584. PubMed ID: 26230338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PEG molecular weight and PEGylation degree on the physical stability of PEGylated lysozyme.
    Morgenstern J; Baumann P; Brunner C; Hubbuch J
    Int J Pharm; 2017 Mar; 519(1-2):408-417. PubMed ID: 28130198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
    Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Batch purification of high-purity lysozyme from egg white and characterization of the enzyme modified by PEGylation.
    Silva Freitas Dd; Abrahão-Neto J
    Pharm Biol; 2010 May; 48(5):554-62. PubMed ID: 20645799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of particle preparation methods and polymorphic stability of lipid excipients on protein distribution in microparticles.
    Liu J; Christophersen PC; Yang M; Nielsen HM; Mu H
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2032-2042. PubMed ID: 28756687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of protein solution by a novel experimental design method using thermodynamic properties.
    Kim NA; An IB; Lee SY; Park ES; Jeong SH
    Arch Pharm Res; 2012 Sep; 35(9):1609-19. PubMed ID: 23054718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and biophysical characterization of lysozyme modified by PEGylation.
    Freitas Dda S; Abrahão-Neto J
    Int J Pharm; 2010 Jun; 392(1-2):111-7. PubMed ID: 20307635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins.
    Zalar M; Svilenov HL; Golovanov AP
    Eur J Pharm Biopharm; 2020 Jun; 151():127-136. PubMed ID: 32283214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polyols on the conformational stability and biological activity of a model protein lysozyme.
    Singh S; Singh J
    AAPS PharmSciTech; 2003; 4(3):E42. PubMed ID: 14621974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, lyophilization and solid-state properties of a pegylated protein.
    Mosharraf M; Malmberg M; Fransson J
    Int J Pharm; 2007 May; 336(2):215-32. PubMed ID: 17207591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcalorimetric study of the adsorption of PEGylated lysozyme and PEG on a mildly hydrophobic resin: influence of ammonium sulfate.
    Werner A; Blaschke T; Hasse H
    Langmuir; 2012 Aug; 28(31):11376-83. PubMed ID: 22830503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermally induced denaturation of lyophilized bovine somatotropin and lysozyme as impacted by moisture and excipients.
    Bell LN; Hageman MJ; Muraoka LM
    J Pharm Sci; 1995 Jun; 84(6):707-12. PubMed ID: 7562408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.
    Wen L; Zheng X; Wang X; Lan H; Yin Z
    Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations.
    Liao YH; Brown MB; Martin GP
    Eur J Pharm Biopharm; 2004 Jul; 58(1):15-24. PubMed ID: 15207533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.
    Banks DD; Cordia JF
    Mol Pharm; 2021 Mar; 18(3):1285-1292. PubMed ID: 33555888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of protein PEGylation on physical stability in liquid formulation.
    Holm LS; Mcumber A; Rasmussen JE; Obiols-Rabasa M; Thulstrup PW; Kasimova MR; Randolph TW; van de Weert M
    J Pharm Sci; 2014 Oct; 103(10):3043-54. PubMed ID: 25139193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein PEGylation attenuates adsorption and aggregation on a negatively charged and moderately hydrophobic polymer surface.
    Pai SS; Przybycien TM; Tilton RD
    Langmuir; 2010 Dec; 26(23):18231-8. PubMed ID: 21067142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
    Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
    Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature dependence of adsorption of PEGylated lysozyme and pure polyethylene glycol on a hydrophobic resin: comparison of isothermal titration calorimetry and van't Hoff data.
    Werner A; Hackemann E; Hasse H
    J Chromatogr A; 2014 Aug; 1356():188-96. PubMed ID: 25016322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.